Cardiff University | Prifysgol Caerdydd ORCA
Online Research @ Cardiff 
WelshClear Cookie - decide language by browser settings

Browse by Current Cardiff authors

Number of items: 4.

Jonas, Brian A., Hou, Jing-Zhou, Roboz, Gail J., Alvares, Caroline L. ORCID:, Jeyakumar, Deepa, Edwards, John R., Erba, Harry P., Kelly, Richard J., Röllig, Christoph, Fiedler, Walter, Brackman, Deanna, Siddani, Satya R., Chyla, Brenda, Hilger-Rolfe, Jacqueline and Watts, Justin M. 2023. A phase 1b study of venetoclax and alvocidib in patients with relapsed/refractory acute myeloid leukemia. Hematological Oncology 41 (4) , pp. 743-752. 10.1002/hon.3159

Dolton, Garry, Rius, Cristina, Wall, Aaron, Szomolay, Barbara ORCID:, Bianchi, Valentina, Galloway, Sarah A.E., Hasan, MD Samiul, Morin, Theo, Caillaud, Marine, Thomas, Hannah L., Theaker, Sarah, Tan, Li Rong, Fuller, Anna, Topley, Katie, Legut, Mateusz, Attaf, Merriem, Hopkins, Jade R., Behiry, Enas, Zabkiewicz, Joanna ORCID:, Alvares, Caroline ORCID:, Lloyd, Angharad, Rogers, Amber, Henley, Peter, Fegan, Chris ORCID:, Ottmann, Oliver ORCID:, Man, Stephen ORCID:, Crowther, Michael D., Donia, Marco, Svane, Inge Marie, Cole, David ORCID:, Brown, Paul E., Rizkallah, Pierre ORCID: and Sewell, Andrew K. ORCID: 2023. Targeting of multiple tumor-associated antigens by individual T cell receptors during successful cancer immunotherapy. Cell 186 (16) , pp. 3333-3349. 10.1016/j.cell.2023.06.020
Item availability restricted.

Chiriches, Claudia ORCID:, Nicolaisen, Nathalie, Wieske, Maria, Elhaddad, Heba, Mehmetbeyoglu, Ecmel, Alvares, Caroline ORCID:, Becher, Dörte, Hole, Paul, Ottmann, Oliver Gerhard ORCID: and Ruthardt, Martin ORCID: 2022. Understanding a high-risk acute myeloid leukemia by analyzing the interactome of its major driver mutation. PLoS Genetics 18 (10) , e1010463. 10.1371/journal.pgen.1010463

Zabkiewicz, Joanna ORCID:, Lazenby, Michelle, Edwards, Gareth, Bygrave, Ceri A., Omidvar, Nader, Zhuang, Lihui, Knapper, Steve ORCID:, Guy, Carol, Hills, Robert K. ORCID:, Burnett, Alan K. and Alvares, Caroline L. ORCID: 2020. Combination of a mitogen‐activated protein kinase inhibitor with the tyrosine kinase inhibitor pacritinib combats cell adhesion‐based residual disease and prevents re‐expansion of FLT3 ‐ITD acute myeloid leukaemia. British Journal of Haematology 191 (2) , pp. 231-242. 10.1111/bjh.16665

This list was generated on Sat May 25 06:20:42 2024 BST.